Cargando…

PSMD9 expression predicts radiotherapy response in breast cancer

BACKGROUND: More than 50% of cancer patients are recommended to receive radiotherapy. Recommendations are based mainly on clinical and pathological factors and not intrinsic tumour radio-sensitivity. Use of radiotherapy according to predictive markers would potentially reduce costly over-treatment,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Langlands, Fiona E, Dodwell, David, Hanby, Andrew M, Horgan, Kieran, Millican-Slater, Rebecca A, Speirs, Valerie, Verghese, Eldo T, Smith, Laura, Hughes, Thomas A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230020/ https://www.ncbi.nlm.nih.gov/pubmed/24673853 http://dx.doi.org/10.1186/1476-4598-13-73

Ejemplares similares

Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast Carcinogenesis
por: Smith, Laura, et al.
Publicado: (2015)

Male breast carcinoma: increased awareness needed
por: White, Jonathan, et al.
Publicado: (2011)

Is surgical diagnostic excision always necessary for solid lesions with atypia?
por: Sharma, Nisha, et al.
Publicado: (2015)

Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer
por: Verma, Rashmi, et al.
Publicado: (2020)

Stromal fibroblasts with nuclear β-catenin are present within breast tumours and increase proliferation and invasion of epithelial breast cancer cells
por: Verghese, E, et al.
Publicado: (2008)

Neoadjuvant Chemotherapy Induces Expression Levels of Breast Cancer Resistance Protein That Predict Disease-Free Survival in Breast Cancer
por: Kim, Baek, et al.
Publicado: (2013)

Differential regulation of oestrogen receptor β isoforms by 5′ untranslated regions in cancer
por: Smith, Laura, et al.
Publicado: (2010)

Expression of phosphorylated eIF4E-binding protein 1, but not of eIF4E itself, predicts survival in male breast cancer
por: Millican-Slater, Rebecca A, et al.
Publicado: (2016)

PSMD9 expression correlates with recurrence after radiotherapy in patients with cervical cancer
por: Köster, Frank, et al.
Publicado: (2020)

PB.40. What happens to the ductal carcinoma in situ in HER2-positive cancers treated with neoadjuvant chemotherapy and trastuzumab?
por: Millican-Slater, R, et al.
Publicado: (2014)

Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response
por: Gwili, Noha, et al.
Publicado: (2021)

Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy
por: Kim, Baek, et al.
Publicado: (2015)

MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion
por: Verghese, Eldo T, et al.
Publicado: (2013)

Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants
por: Al Amri, Waleed S., et al.
Publicado: (2020)

Impact of the first two years of the COVID-19 pandemic on breast cancer diagnoses in England
por: Gathani, Toral, et al.
Publicado: (2023)

The impact of the first 2 years of the COVID-19 pandemic on breast cancer diagnoses: a population-based study in England
por: Gathani, Toral, et al.
Publicado: (2022)

Problems (and solutions) in the study of male breast cancer
por: Speirs, Valerie, et al.
Publicado: (2010)

Change in the use of fractionation in radiotherapy used for early breast cancer at the start of the COVID-19 pandemic: A population-based cohort study of older women in England and Wales
por: Gannon, Melissa, et al.
Publicado: (2022)

Breast cancer cell lines: friend or foe?
por: Burdall, Sarah E, et al.
Publicado: (2003)

Management of breast cancer in an Asian man with post-traumatic stress disorder: a case report
por: Patel, Faaizah, et al.
Publicado: (2016)

26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy
por: Rubio, Andres J., et al.
Publicado: (2021)

Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity
por: Coleman, L J, et al.
Publicado: (2009)

PSMD1 and PSMD2 regulate HepG2 cell proliferation and apoptosis via modulating cellular lipid droplet metabolism
por: Tan, Yanjie, et al.
Publicado: (2019)

PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation
por: Li, Xiao, et al.
Publicado: (2023)

Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B
por: Bencomo-Alvarez, Alfonso E., et al.
Publicado: (2021)

MicroRNA-92 targets the 3' untranslated region of ERβ1 mRNA and post-transcriptionally regulates its expression in breast cancer
por: Alnakhle, HH, et al.
Publicado: (2010)

Evaluation of the use of microbubbles in the ultrasound assessment of the axilla in breast cancer patients
por: Sharma, Nisha, et al.
Publicado: (2015)

Prognostic Significance of PSMD1 Expression in Patients with Gastric Cancer
por: Xiong, Wenjun, et al.
Publicado: (2019)

Upregulation of PSMD4 gene by hypoxia in prostate cancer cells
por: AYDOĞAN TÜRKOĞLU, Sümeyye, et al.
Publicado: (2020)

Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma
por: Zhao, Huihui, et al.
Publicado: (2022)

Haploinsufficiency of PSMD12 Causes Proteasome Dysfunction and Subclinical Autoinflammation
por: Yan, Kai, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on breast cancer referrals and diagnoses in 2020 and 2021: population-based study in England
por: Gathani, Toral, et al.
Publicado: (2021)

Modelling breast cancer in a three-dimensional heterotypic culture system
por: Holliday, DL, et al.
Publicado: (2010)

Na(v)1.5 regulates breast tumor growth and metastatic dissemination in vivo
por: Nelson, Michaela, et al.
Publicado: (2015)

Change in the Use of Fractionation in Radiotherapy Used for Early Breast Cancer at the Start of the COVID-19 Pandemic: A Population-Based Cohort Study of Older Women in England and Wales
por: Gannon, M.R., et al.
Publicado: (2022)

PSMD12 promotes glioma progression by upregulating the expression of Nrf2
por: Wang, Zhongyong, et al.
Publicado: (2021)

PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltration
por: Wang, Song, et al.
Publicado: (2022)

The prognostic role of PSMD14 in head and neck squamous cell carcinoma
por: Schnoell, Julia, et al.
Publicado: (2022)

Endocrine therapy in the years following a diagnosis of breast cancer: A proof of concept study using the primary care prescription database linked to cancer registration data
por: Emanuel, Gabrielle, et al.
Publicado: (2019)

Age and sex can predict cancer risk in people referred with breast symptoms
por: Gathani, Toral, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h5l5jqvg4dgr4jitaioe4co9lh